GSK's 2-drug regimen meets primary goal to control HIV-1

World |  News | 0 Comment | 11 Jul, 2019

ViiV Healthcare, the global specialist HIV company majority-owned by G...Read more

Celsius and J&J sign R&D collaboration agreement

World |  News | 0 Comment | 12 Jul, 2019

Celsius Therapeutics, a company focused on the discovery and developme...Read more

Sandoz extends SYMJEPI™ Injection launch to US

World |  News | 0 Comment | 10 Jul, 2019

Sandoz Inc. (Sandoz), a Novartis division has announced the US retail ...Read more

Lyndra Therapeutics, Gilead Sciences to develop ultra-long-acting HIV therapies

World |  News | 0 Comment | 10 Jul, 2019

Lyndra Therapeutics, the company making daily pills a thing of the pas...Read more

PureTech announces issuance of patent to support its LYT-200 product candidate

World |  News | 0 Comment | 09 Jul, 2019

PureTech Health, an advanced biopharmaceutical company developing...Read more

Cell BT appoints Joshua Ofman to Board of Directors

World |  News | 0 Comment | 09 Jul, 2019

Cell BT, an immuno-therapy company focused on the discovery and d...Read more

BI announces Dabigatran's safety and efficacy for management of VTE in children

World |  News | 0 Comment | 09 Jul, 2019

Boehringer Ingelheim has announced results from two paediatric studies...Read more

WHO prequalifies Mylan HIV self-test

World |  News | 0 Comment | 09 Jul, 2019

Global pharmaceutical company Mylan N.V. and medical device ...Read more

Biocorp strikes €4 M deal with Sanofi for diabetes management

World |  News | 0 Comment | 08 Jul, 2019

French Company Biocorp has entered into exclusive negotiations with Sa...Read more

Sangamo, Pfizer announce updated Phase 1/2 results for SB-525 investigational Hemophilia A gene therapy

World |  News | 0 Comment | 08 Jul, 2019

Sangamo Therapeutics, a genomic medicine company, and Pfizer has ...Read more

FSD Pharma closes deal and acquires Prismic Pharmaceuticals

World |  News | 0 Comment | 08 Jul, 2019

FSD Pharma and Prismic Pharmaceuticals,  a US-based spe...Read more

Facility in Stein (CH) will complement Lonza Pharma & Biotech’s current parenteral drug product offering in Basel (CH)

World |  News | 0 Comment | 05 Jul, 2019

Lonza has announced its entry into a binding ...Read more

GamaMabs Pharma announces result of murlentamab phase 2 study

World |  News | 0 Comment | 05 Jul, 2019

GamaMabs Pharma, a clinical stage biotechnology company developing opt...Read more

Appili signs $3M grant contract with the US Defense

World |  News | 0 Comment | 04 Jul, 2019

Appili Therapeutics Inc. (“Appili”), a biopharmaceutical c...Read more

BioInvent gets IND nod for Phase I/IIa trial of anti-FcγRIIB antibody

World |  News | 0 Comment | 04 Jul, 2019

BioInvent International AB (BINV)  has received authorization fro...Read more

Fosun launches fourth edition of Its acceleration program "Protechting"

World |  News | 0 Comment | 04 Jul, 2019

  Fosun and its portfolio companies Fidelidade, Luz Saude&n...Read more

LEO Pharma completes the acquisition of Bayer’s dermatology business

World |  News | 0 Comment | 03 Jul, 2019

LEO Pharma and Bayer have announced the achievement of the relevant cl...Read more

Hansen adopts NiceLabel technology to support mission-critical production

World |  News | 0 Comment | 03 Jul, 2019

Chr. Hansen develops and produces cultures, enzymes, probiotics and na...Read more